share_log

大成生化科技(00809)进一步延迟刊发2021年经审核年度业绩

Dacheng Biotechnology (00809) further delays the publication of audited annual results in 2021

Zhitong Finance ·  Apr 22, 2022 20:37

Zhitong Financial APP News, Dacheng biochemical Technology (00809) announced that the company is expected to issue an announcement containing the 2021 audited annual results on or before April 30, 2022.

However, in response to the COVID-19 outbreak, a number of cities in China, including Changchun, where the Group's main operation is located, have been cordoned off. it is expected that the audit process (mainly the issuance and receipt of audit confirmation letters to the group's banks, creditors or debtors (the "audit confirmation letter procedure") will not be completed on schedule. The company expects that the process of reviewing the confirmation letter will be completed shortly after the blockade in China is lifted. According to the latest development of the COVID-19 epidemic in Changchun, it is expected that the 2021 audited annual performance announcement will be issued on May 5, 2022.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment